The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Hypoxia-inducible Factor and Its Biomedical Relevance
Open accessAbstract
Oxygen homeostasis is a cornerstone of both the physiology and intermediary metabolism systems. Despite the explosion of knowledge brought about by recombinant DNA technology, links between classic physiology and molecular biology are often fragmentary and tenuous. However, during the past decade, there has been enormous progress in understanding adaptation to hypoxia at the molecular level. A growing number of physiologically relevant genes are up-regulated by falling intracellular oxygen tension via a novel mechanism for oxygen sensing and signaling that triggers the activation of the hypoxia-inducible transcription factor HIF. 1The abbreviations used are: HIF, hypoxia-inducible factor; HRE, hypoxia-responsive element; bHLH, basic helix-loop-helix; NAD, N-terminal activation domain; CAD, C-terminal activation domain; ODD, oxygen-dependent degradation domain; PAS, Per/Arnt/Sim; IPAS, inhibitory PAS; VHL, von Hippel-Lindau; E3, ubiquitin-protein isopeptide ligase; CBP, CREB-binding protein; CREB, cAMP-response element-binding protein; PI3K, phosphatidylinositol 3-kinase; FRAP, FK506-binding protein-rapamycin-associated protein; mTOR, mammalian target of rapamycin; MAP, mitogen-activated protein; E, embryonic day; VEGF, vascular endothelial growth factor; PTEN, phosphatase and tensin homolog deleted from chromosome 10. The importance of this pathway is suggested by its presence in virtually all cells within virtually all higher eukaryotes from flies and worm to man. In this Minireview we summarize a large body of recent information on the oxygen-dependent regulation of the α subunit of HIF, by both ubiquitin-proteasomal degradation and by transcriptional activation. In addition we review some of the biomedical aspects of HIF-dependent gene expression, particularly those that impact angiogenesis and tumor biology. HIF-1 is a transcription factor that binds specifically in hypoxia to a 5′-RCGTG-3′ hypoxia-responsive element (HRE) in the promoter or enhancer of various hypoxia-inducible genes (1Semenza G.L. Annu. Rev. Cell Dev. Biol. 1999; 15: 551-578Crossref PubMed Scopus (1701) Google Scholar), which include erythropoietin, vascular endothelial growth factor, glucose transporters, and glycolytic enzymes, as well as genes involved in iron metabolism and cell survival (1Semenza G.L. Annu. Rev. Cell Dev. Biol. 1999; 15: 551-578Crossref PubMed Scopus (1701) Google Scholar, 2Semenza G.L. Cell. 2001; 107: 1-3Abstract Full Text Full Text PDF PubMed Scopus (808) Google Scholar, 3Wenger R.H. FASEB J. 2002; 16: 1151-1162Crossref PubMed Scopus (1030) Google Scholar). HIF-1 is a heterodimer composed of a 120-kDa HIF-1α subunit and a 91–94-kDa HIF-1β/ARNT subunit, both of which are members of the basic helix-loop-helix (bHLH)-PAS family (1Semenza G.L. Annu. Rev. Cell Dev. Biol. 1999; 15: 551-578Crossref PubMed Scopus (1701) Google Scholar, 3Wenger R.H. FASEB J. 2002; 16: 1151-1162Crossref PubMed Scopus (1030) Google Scholar). PAS is an acronym for the three members first recognized (Per, ARNT, and Sim). Accordingly, HIF-1α and HIF-1β each contain a bHLH domain near the N terminus preceding the PAS domain (Fig. 1). Whereas the basic domain is essential for DNA binding, the HLH domain and N-terminal half of the PAS domain are necessary for heterodimerization and DNA binding (1Semenza G.L. Annu. Rev. Cell Dev. Biol. 1999; 15: 551-578Crossref PubMed Scopus (1701) Google Scholar). Moreover, there are two transcriptional activation domains in HIF-1α; one is referred to here as N-terminal activation domain (NAD) and the other as C-terminal activation domain (CAD). In contrast, HIF-1β contains only one transcriptional activation domain at the C terminus. Furthermore, HIF-1α possesses a unique oxygen-dependent degradation domain (ODD) that controls protein stability. A portion of the ODD overlaps with the NAD. In addition to the ubiquitous HIF-1α, the HIF-α family contains two other members, HIF-2α (also called EPAS1, MOP2, or HLF) and HIF-3α, both of which have more restricted tissue expression (3Wenger R.H. FASEB J. 2002; 16: 1151-1162Crossref PubMed Scopus (1030) Google Scholar). HIF-2α and HIF-3α contain domains similar to those in HIF-1α and exhibit similar biochemical properties, such as heterodimerization with HIF-1β and DNA binding to the same DNA sequence in vitro (1Semenza G.L. Annu. Rev. Cell Dev. Biol. 1999; 15: 551-578Crossref PubMed Scopus (1701) Google Scholar). Despite these similarities, neither HIF1α–/– nor HIF2α–/– embryos can survive (see below), suggesting the lack of functional complementation in vivo within the family. In addition, several HIF-1α variants have been detected (3Wenger R.H. FASEB J. 2002; 16: 1151-1162Crossref PubMed Scopus (1030) Google Scholar). Of particular interest are splice variants HIF-1α516, HIF-1α557, and HIF-1α735 that terminate respectively at codons 516, 557, and 735, resulting in the absence of both NAD and CAD or of CAD only. However, the biological significance of these isoforms
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
(1999) · PubMed · Cited by 2,204
Cited by
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Appelhoff, R. J., Tian, Y.-M., Raval, R. R., Turley, H., Harris, A. L., Pugh, C. W., Ratcliffe, P. J., & Gleadle, J. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406026200 · Cited by 1,108
Ullah, M. S., Davies, A. J., & Halestrap, A. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511397200 · Cited by 890
HIF-1α induces cell cycle arrest by functionally counteracting Myc
Koshiji, M., Kageyama, Y., Pete, E. A., Horikawa, I., Barrett, J. C., & Huang, L. E. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600196 · Cited by 652
Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression
Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L. E., & Song, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606298103 · Cited by 605
HIF1 and oxygen sensing in the brain
Sharp, F. R., & Bernaudin, M. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1408 · Cited by 568
Physiological and pathological responses to hypoxia
Michiels, C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63747-9 · Cited by 559
Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway
Kung, A. L., Zabludoff, S. D., France, D. S., Freedman, S. J., Tanner, E. A., Vieira, A., Cornell-Kennon, S., Lee, J., Wang, B., Wang, J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.009 · Cited by 480
HIF-1 and HIF-2 Transcription Factors - Similar but Not Identical
Loboda, A., Jozkowicz, A., & Dulak, J. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0067-2 · Cited by 477
Koivunen, P., Hirsilä, M., Günzler, V., Kivirikko, K. I., & Myllyharju, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312254200 · Cited by 447
Laderoute, K. R., Amin, K., Calaoagan, J. M., Knapp, M., Le, T., Orduna, J., Foretz, M., & Viollet, B. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00166-06 · Cited by 442
MARXSEN, J. H., STENGEL, P., DOEGE, K., HEIKKINEN, P., JOKILEHTO, T., WAGNER, T., JELKMANN, W., JAAKKOLA, P., & METZEN, E. (2004) · Biochemical Journal · doi:10.1042/bj20040620 · Cited by 386
HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression
Koshiji, M., To, K. K.-W., Hammer, S., Kumamoto, K., Harris, A. L., Modrich, P., & Huang, L. E. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.015 · Cited by 346
Self-citationThe Role of Hypoxia in Glioblastoma Invasion
Monteiro, A., Hill, R., Pilkington, G., & Madureira, P. (2017) · Cells · doi:10.3390/cells6040045 · Cited by 321
Wang, V., Davis, D. A., Haque, M., Huang, L. E., & Yarchoan, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4130 · Cited by 308
Self-citationSimonides, W. S., Mulcahey, M. A., Redout, E. M., Muller, A., Zuidwijk, M. J., Visser, T. J., Wassen, F. W. J. S., Crescenzi, A., da-Silva, W. S., Harney, J., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32824 · Cited by 274
HSP70 Multi-Functionality in Cancer
Albakova, Z., Armeev, G. A., Kanevskiy, L. M., Kovalenko, E. I., & Sapozhnikov, A. M. (2020) · Cells · doi:10.3390/cells9030587 · Cited by 265
Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy
Pringle, K. G., Kind, K. L., Sferruzzi-Perri, A. N., Thompson, J. G., & Roberts, C. T. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp046 · Cited by 259
Hiraga, T., Kizaka-Kondoh, S., Hirota, K., Hiraoka, M., & Yoneda, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2355 · Cited by 242
Hypoxia Inducible Factor Pathway Inhibitors as Anticancer Therapeutics
Burroughs, S. K., Kaluz, S., Wang, D., Wang, K., Van Meir, E. G., & Wang, B. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.17 · Cited by 140
Doege, K., Heine, S., Jensen, I., Jelkmann, W., & Metzen, E. (2005) · Blood · doi:10.1182/blood-2005-03-1138 · Cited by 128
Kaluz, S., Kaluzová, M., & Stanbridge, E. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00552-06 · Cited by 108
Potentiation of Glucocorticoid Activity in Hypoxia through Induction of the Glucocorticoid Receptor
Leonard, M. O., Godson, C., Brady, H. R., & Taylor, C. T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2250 · Cited by 100
(2005) · PubMed · Cited by 72
The oxygen sensing signal cascade under the influence of reactive oxygen species
Acker, H. (2005) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2005.1760 · Cited by 63
Hypoxia inducible factor (HIF) as a model for studying inhibition of protein–protein interactions
Burslem, G. M., Kyle, H. F., Nelson, A., Edwards, T. A., & Wilson, A. J. (2017) · Chemical Science · doi:10.1039/c7sc00388a · Cited by 39
Metadata
- Authors
- Huang, L. E., & Bunn, H. F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 278
- Issue
- 22
- Pages
- 19575-19578
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1506462561
- Cited by
- 315
- References
- 81
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.